Reflux Esophagitis Market, Domestic Brand ‘Fights Hard’

Domestic brands in the market of reflux esophagitis treatments fight well. Especially, among the PPI (Proton Pump Inhibitor) products, Nexium remains strong. However, the domestic pharmaceutical companies are sharpening their spear head.

Based on IMS data in the first half of 2014, compared to the previous year, the PPI products among the major reflux esophagitis treatments have increased by 1...